Technology Brief -- R.P. Scherer Corp.:
   Technology to Be Licensed
   By Pierre Fabre of France
R.P. Scherer will earn licensing fees, royalties on drug
sales and revenues from manufacturing the soft-gel versions
of the Pierre Fabre drugs, a company spokesman said.